Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 714
Out of 5,132 analysts
69
Total ratings
58.33%
Success rate
53.21%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $78.65 | +16.97% | 3 | Jan 5, 2026 | |
| PRCT PROCEPT BioRobotics | Downgrades: Neutral | $55 → $38 | $28.09 | +35.28% | 5 | Dec 8, 2025 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $87.22 | +4.33% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $7.80 | +15.38% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $104.54 | +33.92% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $16.73 | +1.61% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $10.81 | +66.51% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $85.36 | +69.87% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $78.86 | +30.61% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $57.64 | +47.47% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $81.70 | +16.28% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $15.00 | +140.08% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.42 | +434.44% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $9.20 | +1,204.35% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.59 | +436.67% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $22.69 | -42.71% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $13.27 | +216.50% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $478.60 | -51.94% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $365.85 | -37.13% | 4 | Jul 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.05 | - | 3 | Dec 4, 2017 |
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $78.65
Upside: +16.97%
PROCEPT BioRobotics
Dec 8, 2025
Downgrades: Neutral
Price Target: $55 → $38
Current: $28.09
Upside: +35.28%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $87.22
Upside: +4.33%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $7.80
Upside: +15.38%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $104.54
Upside: +33.92%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $16.73
Upside: +1.61%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $10.81
Upside: +66.51%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $85.36
Upside: +69.87%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $78.86
Upside: +30.61%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $57.64
Upside: +47.47%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $81.70
Upside: +16.28%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $15.00
Upside: +140.08%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.42
Upside: +434.44%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $9.20
Upside: +1,204.35%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.59
Upside: +436.67%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $22.69
Upside: -42.71%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $13.27
Upside: +216.50%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $478.60
Upside: -51.94%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $365.85
Upside: -37.13%
Dec 4, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $10.05
Upside: -